Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Mental health

Exposure to SSRIs during pregnancy increases offspring’s risk of speech disorders

Study results show that children born to mothers who took SSRIs during pregnancy were more than a third more likely to have speech/language disorders.

Selective serotonin reuptake inhibitors (SSRIs) can cross the placenta into the foetal bloodstream but few studies have examined whether exposure during pregnancy can affect a child’s language development and scholastic and motor abilities.

To find out, researchers looked at data from 845,345 pregnant women to determine whether or not they had a psychiatric diagnosis during their pregnancy and whether they used SSRIs. They tracked diagnoses of speech, language, scholastic or motor disorders in the women’s children from birth to the age of 14 years.

Children whose mothers were supplied with SSRIs at least twice during their pregnancy had a 37% increased risk of speech/language disorders compared with children born to mothers who were unmedicated.

Reporting their findings in JAMA Psychiatry[1] (online, 12 October 2016), the researchers conclude that exposure to SSRIs during pregnancy increases the risk of speech/language disorders in children.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2016.20202001

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.